Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2024CephalalgiaOpen Access

Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAndrea BurgalassiAzienda Ospedaliero-Universitaria CareggiMRMarina RomozziUniversità Cattolica del Sacro CuoreGVGiulia ViganiAzienda Ospedaliero-Universitaria Careggi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Burgalassi et al. (2024) studied this question.

synapsesocial.com/papers/69dbec255b363cdf1c836302https://doi.org/10.1177/03331024241273968
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Resistant and refractory migraine: clinical presentation, pathophysiology, and management2023 · 55 citations
  2. 2Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study2022 · 50 citations
  3. 3Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition2018 · 10,870 citations
  4. 4New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy2023 · 37 citations
  5. 5Systematic Review of Migraine Prophylaxis Adherence and Persistence2014 · 345 citations